Peng Xin

In silico high-throughput screening system for INMT activators in prostate cancer therapy

Haoyuan Zheng, Cao S, Zhuoling Kong, Peng Xin, Jianbin Bi, Jianfeng Wang

Prostate cancer (PCa) is one of the leading causes of cancer-related mortality in men, with castration-resistant prostate cancer (CRPC) posing significant therapeutic challenges due to drug resistance mediated by the androgen receptor (AR) signaling pathway. Indolethylamine-N-met…Read more